دورية
Completed Induction Phase Analysis of Magnify: Phase 3b Study of Lenalidomide + Rituximab (R 2) Followed By Maintenance in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
| العنوان: | Completed Induction Phase Analysis of Magnify: Phase 3b Study of Lenalidomide + Rituximab (R 2) Followed By Maintenance in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma |
|---|---|
| المؤلفون: | Lansigan, Frederick, Andorsky, David Jacob, Coleman, Morton, Yacoub, Abdulraheem, Melear, Jason, Fanning, Suzanne, Kolibaba, Kathryn S., Reynolds, Christopher M., Nowakowski, Grzegorz S., Gharibo, Mecide, Ahn, Jung Ryun, Li, Ju, Rummel, Mathias J., Sharman, Jeff P. |
| المصدر: | Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p812-812, 1p |
| مستخلص: | Background: Patients with relapsed indolent NHL (iNHL) have limited standard treatment options. Lenalidomide combined with rituximab (R 2) has shown complimentary clinical activity and is a tolerable regimen in both untreated and relapsed or refractory (R/R) patients with iNHL (RELEVANCE : N Engl J Med2018;379:934 and AUGMENT: J Clin Oncol.2019;37:1188). |
| قاعدة البيانات: | Supplemental Index |
Full Text Finder | تدمد: | 00064971 15280020 |
|---|---|
| DOI: | 10.1182/blood-2021-145640 |